Citi Upgrades Bellicum Pharmaceuticals (BLCM) to Buy

August 9, 2016 7:33 AM EDT
Get Alerts BLCM Hot Sheet
Price: $18.06 -3.53%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade BLCM Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Citi upgraded Bellicum Pharmaceuticals (NASDAQ: BLCM) from Neutral to Buy with a price target of $24.00.

For an analyst ratings summary and ratings history on Bellicum Pharmaceuticals click here. For more ratings news on Bellicum Pharmaceuticals click here.

Shares of Bellicum Pharmaceuticals closed at $17.05 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Upgrades

Related Entities

Citi

Add Your Comment